Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Quartz Mountain Resources Raises CA$1.7 Million Via Private Placement

Quartz Mountain Resources Raises CA$1.7 Million Via Private Placement

MT newswireMT newswire2026/10/16 13:04
09:04 AM EDT, 10/16/2026 (MT Newswires) -- Quartz Mountain Resources (QZM.V) closed the private placement of around 4.2 million units raising gross proceeds of CA$1.7 million, it said Friday. The company said 1.5 million FT units were issued to its Chairman Robert Dickinson, and his associates, while 1.5 million units were issued to The Sutton Group Inc, an insider of the company. The company plans to use the net proceeds of the FT units for exploration of its portfolio of British Columbia gold-silver-copper projects, it said. The proceeds of the non-FT units will be used for exploration of its portfolio of British Columbia gold-silver-copper projects and for general working capital purposes, it added. The offering's completion is subject to final approval of the TSX Venture Exchange, said Quartz Mountain Resources.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12